We study genetic epilepsy in a parallel approach with three complementary systems: Drosophila, mice and human iPSC-derived neurons.

Our goal is to understand the underlying cellular mechanisms of the disease and identify targets for development of novel patient-specific therapies in order to reduce and/or eliminate seizures in humans with genetic epilepsy.